Trial
NCT04662073
COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Covid19
Intervention
Camostat
Why stopped
Enrollment into the camostat subprotocol was halted prematurely as a result of loss of equipoise due to external findings including those related to monoclonal antibodies.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-28